サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1467906

乳房病変局在化法の市場レポート：タイプ、用途、エンドユーザー、地域別、2024～2032年

Breast Lesion Localization Methods Market Report by Type, Usage, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 137 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
乳房病変局在化法の市場レポート：タイプ、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の乳房病変局在化法市場規模は、2023年に12億1,420万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに26億5,680万米ドルに達し、2024～2032年の間に8.9％の成長率（CAGR）を示すと予測しています。

乳房病変局在化法とは、病気や傷害によって引き起こされる乳房組織の異常な変化（乳房病変とも呼ばれる）を検出するために採用されるさまざまな手技を指します。一般的に使用される方法には、ワイヤーローカライゼーション、カーボンマーク、ラジオガイド下occult lesion localization（ROLL）、放射性シードローカライゼーション（RSL）、磁気シードローカライゼーション（Magseed）、術中超音波試験（IOUS）などがあります。これらの技術は、医師や医療専門家が十分な情報を得た上で意思決定を行い、患者にとって理想的な治療や手術を決定するのに役立ちます。外科技術、画像技術、生物医療技術の進歩に伴い、乳房病変局在化法は著しく進化しており、現在医療セグメントでの需要を牽引しています。

乳房病変局在化法の市場動向：

ライフスタイルの変化や不健康な食生活による乳がん患者の大幅な増加が、市場成長を牽引する主要要因です。これに加えて、乳腺腫瘤摘出術や外科的生検を必要とする患者数の増加が、標的病変の正確な除去を確実にする乳房病変局在化法の需要を増大させています。さらに、乳がんの早期発見の利点に関する認識を広めるために、さまざまな国の行政機関が積極的な取り組みを行っています。例えば、オーストラリア政府は、2年ごとに50～74歳の女性にマンモグラフィを無料で提供する全国乳がん検診プログラム、BreastScreen Australiaを開始しました。このことは、乳がん診断、生検、その他の関連医療処置に対する政府と民間の償還政策の増加、大手企業による革新的な乳房病変局在化装置の発売と相まって、市場成長の触媒となっています。さらに、研究開発（R&D）活動への重点的な投資が、市場参入企業に有利な機会を提供しています。バストアップなどの美容整形手術を受ける人の増加、医療インフラの改善、技術の進歩、消費者の医療支出の増加などのその他の要因も、市場の展望を明るいものにしています。

本レポートで扱う主要質問

  • 2023年の世界の乳房病変局在化法市場規模は？
  • 2024～2032年にかけての世界の乳房病変局所化法市場の予想成長率は？
  • 世界の乳房病変局所化法市場を牽引する主要因は何か？
  • COVID-19が世界の乳房病変局在化法市場に与えた影響は？
  • 世界の乳房病変局在化法市場のタイプ別区分は？
  • 乳房病変局所化法の世界市場の用途別区分は？
  • 乳房病変局所化法の世界市場のエンドユーザー別区分は？
  • 乳房病変局所化法の世界市場における主要地域は？
  • 乳房病変局所化法の世界市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 乳房病変局在化法の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • ワイヤローカライゼーション
  • 放射性同位元素局在化
  • 磁気トレイサー局在化
  • その他

第7章 市場内訳：用途別

  • 腫瘍同定
  • センチネルリンパ節同定
    • 市場動向
    • 主要セグメント
      • 乳房切除術
      • 乳房切除術
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
  • 診断センター
  • オンコロジークリニック
  • 外来手術センター

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Argon Medical Devices Inc.
    • Becton Dickinson and Company
    • Cook Group Incorporated
    • CP Medical Inc.（Theragenics Corporation）
    • Endomagnetics Ltd.
    • Hologic Inc.
    • IsoAid LLC
    • IZI Medical Products（Landauer Inc）
    • Laurane Medical LLC
    • Leica Biosystems Nussloch GmbH（Danaher Corporation）
    • Merit Medical Systems Inc.
    • Sterylab S.r.l
図表

List of Figures

  • Figure 1: Global: Breast Lesion Localization Methods Market: Major Drivers and Challenges
  • Figure 2: Global: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Breast Lesion Localization Methods Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Breast Lesion Localization Methods Market: Breakup by Usage (in %), 2023
  • Figure 6: Global: Breast Lesion Localization Methods Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Breast Lesion Localization Methods Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Breast Lesion Localization Methods (Wire Localization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Breast Lesion Localization Methods (Wire Localization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Breast Lesion Localization Methods (Radioisotope Localization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Breast Lesion Localization Methods (Radioisotope Localization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Breast Lesion Localization Methods (Magnetic Tracers Localization) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Breast Lesion Localization Methods (Magnetic Tracers Localization) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Breast Lesion Localization Methods (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Breast Lesion Localization Methods (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Breast Lesion Localization Methods (Tumor Identification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Breast Lesion Localization Methods (Tumor Identification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Breast Lesion Localization Methods (Sentinel Lymph Node Identification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Breast Lesion Localization Methods (Sentinel Lymph Node Identification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Breast Lesion Localization Methods (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Breast Lesion Localization Methods (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Breast Lesion Localization Methods (Diagnostic Centres) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Breast Lesion Localization Methods (Diagnostic Centres) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Breast Lesion Localization Methods (Oncology Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Breast Lesion Localization Methods (Oncology Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Breast Lesion Localization Methods (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Breast Lesion Localization Methods (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Breast Lesion Localization Methods Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Breast Lesion Localization Methods Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Breast Lesion Localization Methods Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Breast Lesion Localization Methods Industry: SWOT Analysis
  • Figure 78: Global: Breast Lesion Localization Methods Industry: Value Chain Analysis
  • Figure 79: Global: Breast Lesion Localization Methods Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Breast Lesion Localization Methods Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Usage (in Million US$), 2024-2032
  • Table 4: Global: Breast Lesion Localization Methods Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Breast Lesion Localization Methods Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Breast Lesion Localization Methods Market: Competitive Structure
  • Table 7: Global: Breast Lesion Localization Methods Market: Key Players
目次
Product Code: SR112024A4890

The global breast lesion localization methods market size reached US$ 1,214.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,656.8 Million by 2032, exhibiting a growth rate (CAGR) of 8.9% during 2024-2032.

Breast lesion localization methods refer to various procedures employed to detect abnormal changes in the breast tissue, also called a breast lesion, caused due to a disease or injury. Some commonly used methods include wire localization, carbon marking, radio-guided occult lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization (Magseed), and intraoperative ultrasound (IOUS). These techniques assist doctors and healthcare professionals in making informed decisions and determining the ideal treatment or surgery for the patient. With advancements in surgical, imaging and biomedical technology, breast lesion localization methods have significantly evolved, which is presently driving their demand in the healthcare sector.

Breast Lesion Localization Methods Market Trends:

A significant increase in breast cancer cases due to changing lifestyles, and unhealthy diets represents the primary factor driving the market growth. Besides this, the growing number of patients requiring lumpectomy and surgical biopsy procedures is augmenting the demand for breast lesion localization methods to ensure accurate removal of the target lesion. Additionally, the governing agencies of various countries are taking favorable initiatives to spread awareness regarding the benefits of early detection of breast cancer. For instance, the Government of Australia launched BreastScreen Australia, a national breast cancer screening program that provides a free mammogram to women aged 50-74 every two years. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer diagnosis, biopsy and other related medical procedures and the launch of innovative breast lesion localization devices by leading players, is catalyzing the market growth. Furthermore, heavy investments in research and development (R&D) activities are offering lucrative opportunities to the market players. Other factors, including the rising number of individuals undergoing cosmetic surgeries like breast enhancement, improving healthcare infrastructure, technological advancements, and increasing consumer healthcare spending, are also creating a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global breast lesion localization methods market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, usage and end user.

Breakup by Type:

Wire Localization

Radioisotope Localization

Magnetic Tracers Localization

Others

Breakup by Usage:

Tumor Identification

Sentinel Lymph Node Identification

Lumpectomy

Mastectomy

Breakup by End User:

Hospitals

Diagnostic Centres

Oncology Clinics

Ambulatory Surgical Centers

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Becton Dickinson and Company, Cook Group Incorporated, CP Medical Inc. (Theragenics Corporation), Endomagnetics Ltd., Hologic Inc., IsoAid LLC, IZI Medical Products (Landauer Inc), Laurane Medical LLC, Leica Biosystems Nussloch GmbH (Danaher Corporation), Merit Medical Systems Inc. and Sterylab S.r.l.

Key Questions Answered in This Report

  • 1. What was the size of the global breast lesion localization methods market in 2023?
  • 2. What is the expected growth rate of the global breast lesion localization methods market during 2024-2032?
  • 3. What are the key factors driving the global breast lesion localization methods market?
  • 4. What has been the impact of COVID-19 on the global breast lesion localization methods market?
  • 5. What is the breakup of the global breast lesion localization methods market based on type?
  • 6. What is the breakup of the global breast lesion localization methods market based on the usage?
  • 7. What is the breakup of the global breast lesion localization methods market based on the end user?
  • 8. What are the key regions in the global breast lesion localization methods market?
  • 9. Who are the key players/companies in the global breast lesion localization methods market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Breast Lesion Localization Methods Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Wire Localization
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Radioisotope Localization
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Magnetic Tracers Localization
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Usage

  • 7.1 Tumor Identification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Sentinel Lymph Node Identification
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Lumpectomy
      • 7.2.2.2 Mastectomy
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Centres
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Oncology Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Ambulatory Surgical Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Argon Medical Devices Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Cook Group Incorporated
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 CP Medical Inc. (Theragenics Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Endomagnetics Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Hologic Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 IsoAid LLC
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 IZI Medical Products (Landauer Inc)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Laurane Medical LLC
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Leica Biosystems Nussloch GmbH (Danaher Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Merit Medical Systems Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Sterylab S.r.l
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio